The FDA has proposed the expansion of its Breakthrough Devices program by offering the prioritized premarket review and agency interaction advantages of the Breakthrough Device designation to products that reduce disparities in health and health care. The proposal came in the form of draft guidance issued Oct. 21 that would amend the December 2018 final guidance on the progra... Read More